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Background: To analyze the association of health care costs with predisposing, enabling, and need factors, as
defined by Andersen’s behavioral model of health care utilization, in the German elderly population.
Methods: Using a cross-sectional design, cost data of 3,124 participants aged 57–84 years in the 8-year-follow-up
of the ESTHER cohort study were analyzed. Health care utilization in a 3-month period was assessed retrospectively
through an interview conducted by trained study physicians at respondents’ homes. Unit costs were applied to
calculate health care costs from the societal perspective. Socio-demographic and health-related variables were
categorized as predisposing, enabling, or need factors as defined by the Andersen model. Multimorbidity was
measured by the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Mental health status was measured by the
SF-12 mental component summary (MCS) score. Sector-specific costs were analyzed by means of multiple Tobit
regression models.
Results: Mean total costs per respondent were 889 € for the 3-month period. The CIRS-G score and the SF-12 MCS
score representing the need factor in the Andersen model were consistently associated with total, inpatient,
outpatient and nursing costs. Among the predisposing factors, age was positively associated with outpatient costs,
nursing costs, and total costs, and the BMI was associated with outpatient costs.
Conclusions: Multimorbidity and mental health status, both reflecting the need factor in the Andersen model,
were the dominant predictors of health care costs. Predisposing and enabling factors had comparatively little
impact on health care costs, possibly due to the characteristics of the German social health insurance system.
Overall, the variables used in the Andersen model explained only little of the total variance in health care costs.
Keywords: Cost of illness study, Cross-sectional study, Health care utilization, Health care costs, Multimorbidity,
Elderly, Andersen behavioral modelBackground
Due to demographic change, the proportion of elderly
people in developed countries will increase substantially in
the next decades [1]. Germany is one of the countries
most strongly affected by demographic change with the
proportion of people aged ≥ 65 years expected to rise by
about 50% until 2030 [2]. Due to the progressive increase* Correspondence: d.heider@uke.de
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reproduction in any medium, provided the orin the proportion of elderly people, health care systems
are faced with serious organizational and financial chal-
lenges [3-5]. For a better understanding of the future de-
mand for health care services and health care costs, it is
necessary to understand the specific mechanisms that de-
termine the utilization of health care in the elderly.
As health care utilization is influenced by multiple indi-
vidual and contextual factors, a reasonable starting point
for analyzing health care utilization and costs is to define a
theoretical framework. There are several explanatory frame-
works identifying predictors of health care utilization [6].
One of the most comprehensive and widely usedLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Andersen and J.F. Newman in 1973 [7]. Therein the au-
thors present a causal ordering of health care utilization
within an integrated framework. In the model which has
been discussed and continuously refined over the years
[8-10], it is assumed that individuals’ use of services is a
function of their predisposition to use services (predispos-
ing factors), factors that support or impede use (enabling
factors), as well as their need for health care (illness level).
Predisposing variables pertain to socio-demographic (e.g.
age, sex, education, marital status) and belief characteris-
tics (e.g. values concerning health and illnesses measurable
in consequence such as smoking behavior, alcohol con-
sumption, or body mass index) while enabling factors are
those that support or impede health care service use (e.g.
income, type of health insurance).
According to Andersen and Newman [7], patients’ ill-
ness level (representing the need factor) is considered the
major determinant of health care utilization. In the elderly,
the illness level is often shaped by multimorbidity (MM),
defined as the co-occurrence of two or more chronic con-
ditions in one person without reference to an index dis-
ease [11]. Among the population aged 65+ the prevalence
of MM has been reported to exceed 65% [12-16]. Ap-
proaches to measure MM have quantified the number of
affected clinically relevant physiological systems weighted
by severity [17]. Thus, in the context of the Andersen
model, patients’ illness level may be described by a meas-
ure of MM rather than individual conditions. Linking MM
with health care service use can be a useful strategy for
health services research in general populations where the
focus is on care and costs of the patient as a whole rather
than on the treatment of particular diseases [18,19].
A recent review of the literature asserted the positive
association between MM and health care utilization or
costs in the elderly and pointed out that in studies con-
ducting multivariate analyses MM typically had a much
stronger impact on health care utilization than variables
operationalizing predisposing and enabling factors [20].
However, in many of these analyses, predisposing and
enabling factors such as age, gender, living arrangement,
and health insurance status were still significantly associ-
ated with health service use independent of MM [20]. An-
other recent review of studies that specifically applied the
Andersen model to analyse health service use in various
populations pointed out inconsistencies in the strength
and direction of associations which seemed to be strongly
influenced by the study context and the characteristics of
the study population [21]. Yet, of 16 studies included in
this review, none focussed on the elderly population and
only one was conducted in Germany [22].
The purpose of our study was therefore to analyze the
association of health care costs with predisposing, enab-
ling and need factors as defined by Andersen’s behavioralmodel of health care utilization in a random sample of the
elderly population in Germany. As the German health care
system aims at providing universal access to comprehen-
sive health care services, we were interested in the relative
impact of predisposing, enabling, and need factors in
Germany as compared to findings from the international
literature. We hypothesize that the need factor is much
stronger associated with health care costs in the elderly in
Germany than predisposing and enabling factors.Methods
Sample
This cross-sectional analysis was performed based on 8-
year follow-up data from the ESTHER study, a large
population-based prospective cohort study conducted in
the German federal state of Saarland. The ethics com-
mittees of the Medical Faculty, University of Heidelberg,
and of the Medical Association of Saarland approved the
study which was conducted in accordance with the dec-
laration of Helsinki. Written informed consent was ob-
tained from each participant.
Detailed information about the study design and the
participants of ESTHER has been reported elsewhere
[23,24]. Briefly, baseline recruitment was conducted
between July 2000 and December 2002 and included
9,949 participants aged 50 to 74 years. Standardized
questionnaires on socio-demographic, medical, and
lifestyle factors provided in a postal survey were com-
pleted at the baseline assessment and three follow-ups
(2, 5, and 8 years). Until the 8-year follow-up 499 indi-
viduals deceased and 680 withdrew informed consent,
505 of them due to health reasons.
6,063 individuals participated in the 8-year follow-up
(73.4% response rate) completing the standardized ques-
tionnaires. For 5,056 of these participants, additional infor-
mation was collected with a questionnaire provided to
their GPs. In addition, all 6,063 participants were asked to
take part in an 8-hour geriatric assessment conducted at
their homes by trained study physicians, which also in-
cluded the assessment of health service use to be used for
the present analysis (see below). 3,124 individuals partici-
pated in this geriatric assessment between July 2008 and
December 2010. The analysis presented here is based on
these 3,124 individuals.Variables
Adequate operationalization and selection of variables
representing the Andersen model was ensured by con-
sidering Andersen’s own suggestions [8] as well as the
results of literature reviews by de Boer [25] and Babitsch
[21], which were both largely based on the framework of
Andersen’s behavioral model.
Heider et al. BMC Health Services Research 2014, 14:71 Page 3 of 12
http://www.biomedcentral.com/1472-6963/14/71Predisposing factors
Socio-demographic data include marital status and educa-
tion (years of schooling) supposed to measure social struc-
ture. Age, gender and body mass index (BMI) represent
biological factors that determine a person’s likelihood of
health care utilization. It was calculated based on partici-
pants’ height and weight (kg/m2) as measured by the study
physician during the geriatric assessment.
Enabling factors
Characterized by Andersen as a personal enabling factor,
the participants’ income is reported as the square root
equivalence scale (SRES), which divides the household
income by the square root of the household size [26].
Since the income was assessed per month, the amount
of the SRES was multiplied by 3 to obtain the income
for a 3-month period (see below).
Another personal enabling factor is the participants’
health insurance. In Germany health insurance is
mandatory for the entire population. Approximately
88% of the German population – in particular em-
ployees below a certain income ceiling and their family
members – are insured by the statutory health insur-
ance (SHI) and keep this insurance after retiring. Self-
employed persons and employees above the income
ceiling can opt for private health insurance (PHI) and
usually stay privately insured after retiring. Regardless
of the type of health insurance, all beneficiaries have ac-
cess to outpatient physician and non-physician services,
hospital care, rehabilitation, dental care, prescription
drugs, medical supplies and long-term nursing care. For
those insured by the SHI there are co-payments for
most services but cost-sharing is limited to 2 per cent of
household income per year or even 1 per cent for the
chronically ill. Accordingly, health insurance was di-
vided into the categories ‘statutory’ and ‘private’.
To assess the degree of social isolation and thereby a
community enabling factor, the LSNS-6 [27], a 6-item
short form of the Lubben Social Network Scale [28] was
administered to the respondents. The LSNS was specific-
ally developed for older adult populations. Its single item
categories are defined as “none”, ”one”, “two”, “three or
four”, “five to eight”, “nine or more” persons from family
or friends to whom respondents had contact during a one
month period. Equally weighting the sum of the six items,
the LSNS-6’s total score ranges from 0–30 while the sub-
scale for family and friends ranges from 0–15.
Need
To assess illness level as an indicator of participants’ ob-
jective need of health service use, the Cumulative Illness
Rating Scale for Geriatrics (CIRS-G) [29] was used. The
CIRS-G is a modified version of the Cumulative Illness
Rating Scale [30], which is a well-established measure ofMM in the elderly. On the CIRS-G, 13 categories refer-
ring to clinically relevant physiological systems and 1
category referring to psychiatric illness are rated on a
five-point severity scale ranging from 0 (no problem) to
4 (extremely severe). The 13 physiological systems are
1. heart, 2. vascular, 3. hematopoetic, 4. respiratory, 5.
eyes, ears, nose, throat and larynx, 6. upper gastrointes-
tinal tract, 7. lower gastrointestinal tract, 8. liver, 9. renal,
10. genitourinary, 11. musculoskeletal/integument, 12.
neurological, 13. endocrine/metabolic and breast. Assum-
ing that the impact of the categories is additive, a total
score from the sum of each of the 14 single categories can
be constructed. This total score theoretically ranges from
0 to 56 and simultaneously accounts for the number of
diseases and their severity [17]. The CIRS-G questionnaire
was completed by respondents’ GPs.
Furthermore, since mental health is only reflected to a
small extent in the CIRS-G, subjective mental health sta-
tus was measured based on the SF-12-questionnaire, a
widely used generic questionnaire that does not focus on
specific disease groups. The SF-12 is a downsized version
of the 36 short form health survey (SF-36), in which a sub-
set of 12 items/questions (of the original 36 contained
within the SF-36) is used to derive one summary score
each for physical health (PCS score) and for mental health
(MCS score) [31]. By covering the same dimensions as the
SF-36, i.e. physical functioning (2 questions), role-physical
functioning (2 questions), bodily pain (1 question), general
health (1 question), vitality (1 question), social functioning
(1 question), role-emotional functioning (2 questions), and
mental health (2 questions), while using only one-third of
the items, the SF-12 is able to produce the two summary
scores originally developed for the SF-36 with remarkable
accuracy but far less respondent burden [32]. The SF-12
allows to calculate a mental component summary score
(MCS) for mental health. The score ranges from 0 to 100
and is standardized to population norms (based on a US
norm-sample), with the mean score set at 50 (SD = 10);
lower scores indicate worse, and higher scores better men-
tal health. The SF-12 has good psychometric properties
[31] and measures subjective Health-Related Quality of
Life (HRQOL).
Health care use
Based on a questionnaire on health service utilization
developed by our working group on the specific de-
mands of the German health care system and used in
previous studies [33,34], a short health economic ques-
tionnaire, especially suited for the application in large
epidemiologic studies, was developed within the project.
The questionnaire is available from the authors upon
request. It covers in-patient care, out-patient physician
services, out-patient non-physician services (physical or
occupational therapy), medical supplies and dental
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out-of-pocket expenses for the corresponding categories
(Table 1). Assessment was retrospective for a period of
3 months for all resources and services. In order to
minimize recall bias, the questionnaire contains lists of
common health services and goods used in old age.
Pharmaceuticals were recorded during home visits by
the study doctors by means of a barcode reader when
respondents had packages available and by hand other-
wise. Missing drug codes were searched using available
information on trade name and pharmaceutical form.
The health economic questionnaire was administered in
personal interviews conducted by the study physicians
during the geriatric assessment at respondents’ homes.
Health care costs
By recording all used resources and services, regardless of
whether they were covered by health or nursing care in-
surance or paid for out-of-pocket, a societal perspective
was adopted in this analysis. The cost categories analyzed
in this study are direct costs of illness arising from the use
of resources. Costs were calculated from resource use as
recorded in the questionnaire by means of unit costs. Re-
source categories and sources of unit costs are listed in
Table 1.
Pharmaceuticals were monetarily valued using German
PZN-codes as recorded in the home visit in conjunction
with the MMI Pharmindex database [45]. Medication
taken occasionally was valued by means of the pharmacy
retail price of one package per 3 months (using the pack-
age size as recorded). For continuous medication, costs
per unit of the drug were derived from the recorded pack-
age size and the corresponding pharmacy retail price, and
3-month costs were obtained by multiplication of the unit
cost with the total dose for the 3-month period.
Informal care was valued using the replacement cost
approach, i.e. it was assumed that the same amount of
care by professional nursing services would have had to
be paid for in the absence of an informal caregiver. Ac-
cordingly, hours of informal care were valued using the
same hourly wage rate as for professional home care.
Methods for the valuation of informal care are discussed
by van den Berg et al. [49].
Costs were calculated in € at 2009 price levels. Unit
costs that were unavailable at year 2009 values were in-
flated or deflated to year 2009 price levels by means of
the consumer price index [50].
For statistical analysis, we categorized cost data as fol-
lows: 1) Costs of inpatient care comprising inpatient
treatment in general hospitals, specialized psychiatric
and neurological hospitals or rehabilitation hospitals;
2) costs of outpatient care comprising outpatient physician
treatment, other outpatient treatment, medical supplies
and dental prostheses; 3) costs of medication comprisingpharmaceuticals; 4) costs of nursing care comprising nurs-
ing home care, professional community nursing care and
informal care.
Missing values
With the exception of items of the health economic ques-
tionnaire, missing values were imputed by means of mul-
tiple imputation by chained equations using the program
ice [51] in STATA Release 12 [52]. The last column in
Table 2 gives an overview of the percentages of missing
values in the single variables. For the imputation procedure
a cycle length of 200 was chosen. A graphical analysis
showed that this was sufficient for convergence of the im-
putations. Following the suggestions of van Buuren [53,54],
we calculated 100 imputation steps as the recommendation
of only 5 imputations by Rubin [55] seemed to be too small
for the task. Beyond the variables contained in Table 2, the
following variables were entered into the multiple imput-
ation model: SF-12 physical component score, Barthel
Index, Mini Mental State Examination score, smoking sta-
tus, alcohol intake and hand strength. The single sectors of
health care costs were part of the imputation model but
were not imputed themselves. For the imputation the level
of measurement of the particular variables was considered.
Imputed values were restricted to the theoretical range of
the original variable.
Missing values in items of the health economic ques-
tionnaire and dosage of medication were not part of the
multiple imputation model since these variables were too
numerous and too varied to be imputed meaningfully.
Therefore costs of medication with missing values for dos-
age were calculated using a conservative rule, whereby the
pharmacy retail price of one package of the drug per
3 months was applied. Missing values in the resource use
questionnaire were set at zeros, resulting in a conservative
estimation of the health care service use and costs.
Statistical analysis
“To assess the associations of covariates with health care
costs, multiple Tobit regression models with marginal ef-
fects for the unconditional expected value E[y] of the
dependent variable were estimated. Tobit regression
models were used because resource use and cost data as
used in our study often fall under the category of so-called
corner solution outcomes. That is, the dependent variable
“…y takes on the value zero with positive probability but is
a continuous random variable over strictly positive values”
[56]. In contrast to censored data where the “real” values
for the zeros are unknown, data observability is no issue
in corner solution applications. Following Woolridge’s [56]
suggestions, we decided to present the marginal effects for
the unconditional expected value E[y] of the dependent
variable. These marginal effects are the most useful and
informative measure since they provide information which
Table 1 Recorded resources, units of measurement and unit costs used for calculation of costs in the primary analysis
Sector Resources Units Unit costs (source)
In-patient treatment Stays in general hospitals, specialized psychiatric
and neurological hospitals or rehabilitation clinics
(including day patient treatment)
Days in hospital Calculated costs of care per day by type
(Federal Statistical Office, German Hospital
Federation, Statutory Pension Insurance Fund) [35-37]
Out-patient physician treatment Treatment by GPs, specialists and out-patient clinics Number of contacts Calculated costs per contact, by specialization [38]
Other out-patient treatment E.g. physiotherapy, massage, occupational therapy,
non-medical practitioner
Number of contacts Reimbursement schedules (Statutory health
insurance funds; [39-41], calculated costs per contact [38],
by type, schedule of fees (Federal office of administration) [42]
Medical supplies and dental prostheses E.g. walkers, incontinence pads, hearing aids,
surgical stockings, dental bridge, crown
Quantity Reimbursement schedules (Statutory health insurance funds,
Federal Association of Panel Dentists; [43,44], calculated costs
per item [38], by type
Pharmaceuticals Specific products (including trade name, drug code,
package size, pharmaceutical form, dosage)
Quantity Pharmacy retail prices (MMI-Pharmindex,
Medizinverlag Medizinische Medien Informations
GmbH (MMI, Neu-Isenburg) [45]
Nursing home care Nursing home stays (residential and day care) Days Calculated costs of care per day
(Federal Statistical Office) [46], by type
Professional home care Care and assistance provided by professional
nursing services and other paid help, differentiated
by type (e.g. basic care, assistance with cleaning,
shopping, financial matters etc.) and limited to care
or assistance required owing to illness or age
Hours Hourly gross wage rate plus non-wage labor costs for
employees in the domain of care and assistance for the
elderly or handicapped (Federal Statistical Office) [47,48]
Informal care Care and assistance provided by family or friends,
differentiated by type and limited to care or
assistance required owing to illness or age
Hours Replacement cost method: Hourly gross wage rate plus
non-wage labor costs for employees in the domain of
care and assistance for the elderly or handicapped





















Table 2 Socio-demographic and health related sample characteristics (grouped by predisposing characteristics,
enabling resources and need)
Characteristics All Male Female p-valuea Missing
values (%)n = 3,124 n = 1,481 n = 1,643
Predisposing characteristics Age
Mean (SD) 69.6 (6.3) 70.0 (6.2) 69.3 (6.4) <0.01 0.0
Range 57-84 58-83 57-84
Marital status: n (%)
Single 105 (3.4) 54 (3.7) 51 (3.1) <0.01 1.2
Married 2,217 (71.8) 1,244 (85.0) 973 (59.9)
Divorced 229 (7.4) 66 (4.5) 163 (10.0)
Widowed 536 (17.4) 99 (6.8) 437 (26.9)
Education: n (%)
≤ 9 years of schooling 2,038 (66.2) 916 (62.7) 1,122 (69.3) <0.01 1.4
10-11 years of schooling 550 (17.9) 211 (14.5) 339 (20.9)
≥ 12 years of schooling 491 (16.0) 333 (22.8) 158 (9.8)
Body mass index: mean (SD) 28.7 (4.8) 28.9 (4.3) 28.5 (5.2) 0.02 0.1
Enabling resources Incomeb: mean (SD) 4,299.1 (2,053.9) 4,483.4 (2,070.9) 4,123.5 (2,022.7) <0.01 13.1
Health insurance: n (%)
Statutory 2,859 (92.2) 1,323 (90.0) 1,536 (94.2) <0.01 0.8
Private 241 (7.8) 147 (10.0) 94 (5.8)
Lubben social network scale: mean (SD)
Family 9.4 (2.9) 9.3 (2.9) 9.4 (2.9) 0.31 0.5
Friends 7.6 (3.4) 7.5 (3.5) 7.7 (3.3) 0.08 0.7
Need CIRS-G score: mean (SD) 6.9 (5.4) 7.1 (5.6) 6.6 (5.3) 0.02 16.8
SF-12 summary scores: mean (SD)
Mental component summary (MCS) score 47.8 (9.8) 49.0 (9.0) 46.7 (10.3) <0.01 3.3
aDifferences in proportions: χ2-test; differences in means: t-test; bsquare root equivalent scale for 3 months (SRES).
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the pooled results, necessary because of the multiple im-
puted data, the software MIM was used [57]. Pseudo-R2s
and Chi2s were estimated with reference to [58]. The level
of significance was set at α = 0.05. All statistical analyses
were performed using STATA Release 12 [52].Results
Sociodemographic characteristics and missing values
The sample consisted of 3,124 respondents of whom 1,481
(47.4%) were male. The mean age was 69.6 years. Most of
the respondents were married (71.8%), had less than
10 years of schooling (66.2%) and were covered by statutory
health insurance (92.2%). The mean BMI was 28.7 and the
mean SRES income for 3 months was 4,299 €. The mean
CIRS-G score was 6.9 and the mean SF-12 MCS score was
47.8. Compared to women, men were slightly older, more
often married, had more years of schooling, had a slightly
higher BMI, had a higher income, were privately insured
more frequently and had a higher level of multimorbidity(CIRS-G score) as well as a slightly better mental health
status (SF-12 MCS score) (all p < 0.05).
Rates of missing values were highest on the income
variable (13%) and the CIRS-G (17%). On all other vari-
ables missing rates were rather negligible with 0% for
age and 3.3% for the SF-12 MCS score. Nevertheless,
the missing values on all variables cumulated to a num-
ber of 681 (21.8%) incomplete cases. For further details
of socio-demographic and health-related sample charac-
teristics see Table 2.
Health care utilization
98% of the respondents consumed at least one health
care service or good during the 3 months preceding
the interview (Table 3). The highest rates of service
utilization appeared for outpatient physician services
(95%) and pharmaceuticals (85%). Inpatient care was
used by 9%. Non-physician providers, medical supplies
and dental prostheses were used by 20% and 24%, re-
spectively. The utilization of nursing care was rather
low with 0.9% for formal and 1.7% for informal care.
Table 3 Service utilization and costs in € (year 2009 values) during 3-month period
Number (%) of users Mean costs in € per respondent (SD)
Resource All Male Female All Male Female p-valuea
n = 3,124 n = 1,481 n = 1,643 n = 3,124 n = 1,481 n = 1,643
Inpatient care 272 (8.7) 129 (8.7) 143 (8.7) 393.3 (1850.3) 379.4 (1773.2) 405.9 (1917.6) 0.69
Outpatient care
Outpatient physician services 2,973 (95.2) 1,403 (94.7) 1,570 (95.6) 174.2 (234.7) 169.2 (261.9) 178.7 (207.1) 0.26
Non-physician providers 633 (20.3) 255 (17.2) 378 (23.0) 29.3 (92.6) 24.6 (70.2) 33.5 (108.7) 0.01
Medical supplies and dental prostheses 750 (24.0) 315 (21.3) 435 (26.5) 68.6 (412.7) 65.1 (442.8) 71.7 (383.5) 0.66
Pharmaceuticals 2,688 (85.4) 1,262 (85.2) 1,406 (85.6) 171.1 (290.7) 182.9 (303.2) 160.5 (278.6) 0.03
Nursing care
Formal 29 (0.9) 10 (0.7) 19 (1.2) 8.44 (155.7) 6.8 (174.8) 9.9 (136.2) 0.59
Informal 54 (1.7) 23 (1.6) 31 (1.9) 43.5 (547.1) 62.5 (715.6) 26.4 (327.1) 0.07
Any service or good 3,061 (98.0) 1,445 (97.6) 1,616 (98.4) 888.5 (2181.6) 890.5 (2225.0) 886.6 (2142.4) 0.96
aSimple OLS regression with bootstrapped standard errors (4,000 replications).
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be slightly higher for women.
Health care costs
The mean total costs per respondent for the 3-month
period were 889 € (Table 3). With 393 € per respondent,
inpatient care was the sector with the highest mean costs
followed by outpatient physician services (174 €) and
pharmaceuticals (171 €). Mean costs of medical supplies
and dental prostheses (69 €), informal nursing care (44 €)
and non-physician providers (29 €) were comparatively
low. With 8 € per respondent, mean costs of formal nurs-
ing care were lowest. Mean costs of non-physician pro-
viders were significantly higher for females (72 € vs. 65 €),
while mean costs of pharmaceuticals were significantly
higher for males (183 € vs. 161 €).
Health care costs of users
Looking at mean health care costs for the 3-month period
of only those respondents who used respectively services or
goods, inpatient care (4,518 €), followed by informal nurs-
ing care (2,515 €) and formal nursing care (909 €), were the
three most costly sectors (Table 4). Mean costs per user in
all other sectors were comparatively low with 286 € for
medical supplies and dental prostheses, 200 € for pharma-
ceuticals, 183 € for outpatient physician service and 145 €
for non-physician providers. For pharmaceuticals and infor-
mal nursing care, the mean costs for users of health care
services were significantly higher in males than in females.
Regression analyses
The results of the regression analyses (Table 5) revealed
that the CIRS-G score and the SF-12 MCS score, repre-
senting the need factor in the Andersen model, were con-
sistently associated with total, inpatient, outpatient and
nursing costs: A one point increase in the CIRS-G scorewas associated with an increase of 18 € in 3-month in-
patient costs, 17 € in outpatient costs and 3 € in nursing
costs. This aggregates to an increase of the total costs of
41 € per score point of the CIRS-G. The SF-12 MCS score
was inversely related to all cost sectors, resulting in a total
cost decrease of 14 € per MCS score point.
Of the socio-demographic variables representing predis-
posing factors in the Andersen model, only respondents’
age was significantly positively associated with inpatient
costs (10 € per year of age), outpatient costs (3 € per year
of age), nursing costs (3 €) and total costs (13 €). The BMI
was associated significantly with outpatient costs, with a
6 € increase per kg/m2 and total costs with a 11 € increase
per kg/m2. 12 or more years of schooling significantly de-
creased inpatient costs by an amount of 161 €. Neither in-
come nor health insurance status or Lubbens social
network scale, representing enabling factors of the Ander-
sen model, were associated with costs in any sector.
Denoted by the constants of the four regression models,
the average 3-month cost per respondent, controlled for all
covariates, was 843 € for total costs; 349 € for inpatient
costs; 447 € for outpatient costs and 47 € for nursing costs.
Discussion
In our study we analyzed health care costs of the elderly
population in Germany. In order to organize and categorize
the multiple factors which may influence health care
utilization, we applied the theoretical framework developed
by Andersen and Newman which distinguishes predispos-
ing, enabling and need factors.
The main finding of our study is that the need factor of
the Andersen model, operationalized through a measure of
MM (CIRS-G) and complemented by a measure of mental
health status (SF-12 MSC), was the dominant and most
consistent predictor of health care costs. In our study a one
Table 4 Costs in € (year 2009 values) during 3-month period for users of respective services
Mean costs in € per respondent (SD)
Resource All Male Female p-valuea
n = varies n = varies n = varies
Inpatient care 4,517.7 (4,555.4) 4,355.6 (4,347.4) 4,663 (4,745.7) 0.56
Outpatient care
Outpatient physician services 183.0 (237.2) 178.6 (266.0) 187.0 (208.2) 0.35
Non-physician providers 144.6 (160.1) 143.1 (108.3) 146.1 (181.4) 0.83
Medical supplies and dental prostheses 285.6 (804.9) 306.1 (922.1) 270.8 (708.8) 0.57
Pharmaceuticals 200.4 (305.1) 214.7 (318.0) 187.6 (292.6) 0.02
Nursing care
Formal 909.2 (1361.9) 1,011.0 (1,974.1) 855.7 (963.3) 0.81
Informal 2,515.8 (3,361.4) 4,021.5 (4,219.4) 1,398.6 (1,968.5) <0.01
Any service or good 906.8 (2,200.2) 912.7 (2,248.1) 901.4 (2,157.1) 0.89
aSimple OLS regression with bootstrapped standard errors (4,000 replications).
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crease in total costs of 41 € per 3 months. The finding
that higher levels of MM lead to higher health care
costs is in line with most comparable studies conducted
in elderly populations and emphasizes the relevance of
elderly’s need of health care. In a systematic review of
the international literature, Lehnert et al. [20] found
ample evidence of a positive association between MM
and health care costs. Similar to our study, hospital
stays [18,59], physician visits [60,61] and pharmaceuti-
cals [62-64] were reported to elevate health care costs
with each additional chronic condition.
Over and above the need factor, predisposing and enab-
ling factors explained only little of the variance of costs. Of
the predisposing factors, only age, the BMI and 12 or more
years of schooling were found to be significant predictors
of costs. The association found between age and costs
seems to contradict the finding of a review conducted by
de Boer [25], which found no definite influence of age on
health care utilization in her review. However, de Boer’s
findings apply to populations of chronically ill people,
whereas our findings are based on a representative random
sample of the elderly German general population. Further-
more, in a recent review the direction of the association
between age and the utilization of health care services was
found to be dependent on specific characteristics of the
study population [21]. Of all other variables characterized
as predisposing factors in the Andersen model, only the
BMI demonstrated a cost-increasing effect of potentially
inadequate health behavior. Yet, this only holds for out-
patient and total costs. We could not detect a significant
cost-increasing effect of female gender [22,65] or high edu-
cation [66,67] as reported for health service use by other
studies that applied the Andersen model. Instead, we found
a cost-reducing effect of 12 or more years of schooling on
inpatient costs with an amount of 161 €. Nor did we find asignificant association of marital status and health care
costs; yet, associations of marital status and health service
use have been reported in different directions by other
studies applying the Andersen model [68,69].
Neither respondents’ income nor their health insurance
status, representing enabling factors of the Andersen
model, was significantly associated with health care costs.
By contrast, studies conducted in other countries, in par-
ticular the USA [66,70,71] , have repeatedly reported posi-
tive associations of insurance, income and costs. Since in
our study the difference between statutory and private
health insurance regarding total costs was rather high
(227 €), the lack of significance of this effect might be
caused by the relatively small number of privately insured
respondents (7.8%). Yet, the lack of association of income
and costs may be due to the specifics of the German
health care system which is characterized by relatively low
financial barriers to the utilization of comprehensive
health care services (in particular by limiting co-payments
to a maximum of 2% of income), despite undoubtedly
existent income inequalities.
Possible reasons why predisposing and enabling factors
explained only little of the variance in costs may be insuffi-
cient operationalization and variable selection for the pre-
disposing and enabling factors. While there is no fixed set
of predisposing and enabling variables defined for the An-
dersen model, our choice of variables was strongly oriented
by Andersen’s suggestions, thereby trying to keep the re-
gression models preferably parsimonious. However, as
pointed out by Babitsch [21], an unambiguous assignment
of a variable to one single factor is not always possible. In
fact, we used variables similar to those used by other stud-
ies that applied Andersen’s framework: a recent review of
studies that applied the Andersen model found the most
frequently used variables for the predisposing factor to be
age, marital status, gender, education and ethnicity [21].
Table 5 Multiple Tobit regression analyses with mean costs in 3-month period in € (year 2008 values) as dependent variable for total costs and by health
care sector
Predictor variables Total costs Inpatient costs Outpatient costs Nursing costs
b (SE) (p-value)a b (SE) (p-value)a b (SE) (p-value)a b (SE) (p-value)a
Predisposing factors Age (centered) 13.33** (4.33) (0.002) 9.51* (4.34) (0.028) 3.44* (1.41) (0.015) 2.70*** (0.62) (0.000)
Female gender (ref: male) 21.65 (55.06) (0.694) 53.46 (55.52) (0.336) −12.91 (17.89) (0.471) −2.70 (6.58) (0.682)
Marital status (ref: married)
Single 139.92 (148.79) (0.347) 208.98 (187.53) (0.265) −5.57 (45.92) (0.903) 30.72 (30.40) (0.312)
Divorced 103.85 (104.36) (0.320) 246.97 (139.17) (0.076) −23.71 (32.22) (0.462) 6.68 (15.69) (0.670)
Widowed 79.49 (74.99) (0.289) 146.20 (84.96) (0.085) −16.02 (23.70) (0.499) 6.57 (8.98) (0.465)
Education (ref: ≤ 9 years of schooling)
10-11 years of schooling −14.95 (69.77) (0.830) −46.73 (65.42) (0.475) 41.26 (23.29) (0.077) 9.80 (10.64) (0.357)
≥ 12 years of schooling −122.42 (76.53) (0.110) −160.88** (62.54) (0.010) −26.87 (25.35) (0.289) 2.40 (10.25) (0.815)
Body mass indexc 11.37* (5.37) (0.034) 1.74 (5.25) (0.740) 5.88** (1.75) (0.001) 0.54 (0.59) (0.362)
Enabling Incomeb c 0.02 (0.043) (0.653) 0.03 (0.04) (0.505) 0.02 (0.014) (0.107) −0.01 (0.01) (0.382)
Private health insurance (ref: statutory) 146.31 (106.51) (0.170) 175.79 (130.97) (0.180) 54.08 (34.31) (0.115) 0.85 (14.65) (0.954)
Lubben social network scalec 4.53 (5.17) (0.381) 5.92 (5.06) (0.242) −1.01 (1.68) (0.548) 0.31 (0.58) (0.596)
Need CIRS-G scorec 41.18*** (5.05) (0.000) 18.23*** (4.77) (0.000) 17.19*** (1.64) (0.000) 3.05*** (0.68) (0.000)
SF-12 Mental component summary (MCS)c −13.90*** (2.72) (0.000) −8.71*** (2.59) (0.001) −3.56*** (0.89) (0.000) −1.14*** (0.33) (0.001)
Averaged pseudo R2 0.003 0.008 0.004 0.007
Averaged Chi2 158.04 58.52 195.52 139.65
aMultiple Tobit regression with marginal effects for the unconditional expected value E[y] of the dependent variable; bsquare root equivalence scale for 3 months; *p <0 .05; **p < 0.01; ***p < 0.001; SE = standard error;
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not be as relevant in Germany as, for example, in. the USA
[66,70], but still may have explained some additional vari-
ance in costs. For the predisposing factor, the most fre-
quently used variables reported by the mentioned review
were income, health insurance and having a usual family
doctor. We did not include the latter variable, as the study
sample was recruited via their GPs. Yet we followed the
suggestion to expand Andersen’s original model by the in-
clusion of the social network, following Pescosolido’s
Network-Episode Model [72] “larger, more supportive net-
works decrease the use of patterns of care”. Although not
significant, the effect of the Lubben Social Network Scale
characterizes the Social Network as a potential cost driver
in our study with 5 € per scale point. This might be due to
the fact that compared to network analysis as practiced by
Pescosolido, the Lubben scale is a rather basic construct
and therefore potentially unable to depict the expected as-
sociations. Furthermore, the impact of the Social Network
may depend on cultural aspects.
Mean total costs per respondent for a 3-month period
were 889 € which - extrapolated to a 12 month period –
corresponds to 3556 € per year. This figure is similar to
annual total costs of 3315 € and 3730 €, respectively, re-
cently reported by Nagl et al. [73] and Heinrich et al. [74]
for similar samples of the elderly population in Germany.
Similar to a study conducted in Germany by Nagl et al.
[73], we found inpatient care, outpatient care and pharma-
ceuticals to be the three most costly health care sectors.
However, amounting to 25% in the study by Nagl et al.,
their proportion of inpatient care was 19% lower than in
our study. This might have been caused by the different
time period of 12 months used by Nagl et al. vs. the 3-
month period in our study. Since the utilization of in-
patient care is a much rarer event than the use of out-
patient care and pharmaceuticals, this in conjunction with
the implementation of face to face interviews by trained
study physicians in our study could have led to a reduction
of recall bias and therefore more valid representation of
inpatient costs as opposed to the study by Nagl et al.,
which used telephone interviews.Limitations
Our study is based on a large and nearly representative
sample of the German elderly population [23,24]. Yet the
number of users of nursing care in our sample was very
low. This is likely due to the inability or unwillingness of
nursing care recipients to complete a 2-hour home inter-
view. A consequence of this selection process would be
the underrepresentation of those with the highest level of
MM and therefore an underestimation of the health care
costs. This might have also influenced the prediction of
the health care costs in the regression analysis.We collected comprehensive data on health service
utilization from a societal perspective. Yet the period of
3 months for which data was collected was rather short,
possibly increasing the variance of calculated health
care costs, which may be a further reason for the vari-
ance explained by the models being only small. On the
other hand, this short period likely may have enhanced
the accuracy of collected information about health care
utilization because of less memory bias in participants’
responses.
We used detailed information on morbidity from
which we calculated a well-established and - due to the
assessment by GPs - objective measure of MM. How to
best measure MM in this context is uncertain and needs
further investigation. Research comparing the predictive
ability of various MM measures on different health care
related outcomes has produced inconclusive results
[75-79], suggesting that no single measure of MM will
completely capture the differences in the study subjects’
underlying illness level.
The conclusions from the results of the regression
models hold only under the assumption that all missing
values were at random (MAR). The cross-sectional study
design provides only limited evidence of the causal asso-
ciations between predictor and outcome variables.Conclusions
MM and mental health status, both representing the
need factor in the Andersen model, were the dominant
predictors of health care costs. Predisposing and enab-
ling factors had comparatively little impact on health
care cost, possibly due to specific conditions of the German
health care system. Overall, the variables used in the
Andersen model explained only a small proportion of
the total variance in health care costs. Whether this in-
dicates room for further improvement of the Andersen
model or its limited ability to predict costs in general
should be investigated in future studies. Different com-
binations of potential predictors of costs should be
tested in various health care systems, as service use and
costs in Germany are likely to differ from other coun-
tries. Nevertheless, in view of the predicted demo-
graphic change in developed countries, MM as a major
cost driver has to be considered a key factor when plan-
ning future resource allocation. The development and
implementation of integrated care models for patients
with multiple chronic diseases and preventive programs
aiming at modifiable risk factors could be options to re-
duce the financial strain of multimorbidity on health
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